Alternations of Transcriptional Regulation in Oral Cancers and Analysis of Tumor Suppressive functions of p300 Transcriptional Co-activator
Alternations of Transcriptional Regulation in Oral Cancers and Analysis of Tumor Suppressive functions of p300 Transcriptional Co-activator
批准号:
13470399
负责人:
IKEDA Masa-aki
金额:
$9.22万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The p300 acetyltransferase/transcriptional coactivator plays key roles in the regulation of cell proliferation and differentiation. Although p300 is targeted for mutations in human carcinomas, a role for p300ICBP in tumorigenesis is still remains poorly understood. In this study, we have identified p300 in two lines of human carcinoma cells (Ohshima et al. 2001, Suganuma et al. 2003). We have demonstrated that reintroduction of wild-type p300 suppressed growth of human carcinoma cells lacking normal p300, and that p300 plays an important role in the TGFJ3 signaling pathway, which is important for the negative regulation of epithelial cell growth (Suganuma et al. 2003).To further elucidate mechanisms of tumorigenesis of oral carcinomas, we have investigated regulation of the RB tumor suppressor protein and the interaction between chromatin DNA and nuclear matrix. We have obtained several observations. (1) Cytoplasinic sequestration of cyclin D1, which is critical for RB phosphorylation, plays an important role for cell cycle exit and survival of terminally differentiated cardiomyocytes and neurons, respectively (Tamamori-Adachi et al. 2003ÅASumrejkanchanakij et al. 2003). (2) The nuclear-matrix-binding protein E2FBP1/DRIL1 is regulated by the p53 tumor suppressor (Ma et al. 2003). (3) Distinct recruitment of transcription regulatory complexes to chromatin DNA mediates activation and repression of an E2F target gene, which is regulated by the RB family proteins (Araki et al. 2003).
期刊论文(126)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
馬凱文: "p53の増殖抑制能におけるARIDファミリー蛋白質E2FBP1の関与"口腔病学会雑誌. 69. 152-161 (2002)
马凯文:“ARID 家族蛋白 E2FBP1 参与 p53 的生长抑制能力”口腔医学会杂志 69. 152-161 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamamorl-Adachi, M., et al.: "Expression of cyclin Dl and CDK4 causes hypertrophic growth of cardiomyocytes in culture: a possible implication for cardiac hypertrophy"Biochemical and Biophysical Re-search Communications. 296. 274-2880 (2002)
Tamamorl-Adachi,M.等人:“细胞周期蛋白D1和CDK4的表达引起培养物中心肌细胞的肥大生长:心脏肥大的可能暗示”生物化学和生物物理研究通讯。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nagai, A., et al.: "Exposure of neonatal rats to diethyl-stilbestrol affects the expression of genes involved in ovarian differentiation."J.Med.Dent.Sci.. 50. 35-40 (2003)
Nagai, A., et al.:“新生大鼠接触己烯雌酚会影响卵巢分化相关基因的表达。”J.Med.Dent.Sci.. 50. 35-40 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Auerkari E.I., et al.: "Expression of p16(INK4a) in tumors."Oral Oncology.. 9. 241-246 (2003)
Auerkari E.I. 等人:“p16(INK4a) 在肿瘤中的表达。”口腔肿瘤学.. 9. 241-246 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
池田 正明(分担): "発生における細胞増殖制御(竹内隆・岸本健雄 編)"シュプリンガー・フェアラーク東京. 9 (2004)
Masaaki Ikeda(撰稿人):“发育过程中的细胞增殖控制(由 Takashi Takeuchi 和 Takeo Kishimoto 编辑)”Springer Verlag Tokyo 9 (2004)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 52 条
Regulation of Chromatin Remodeling and Transcription Involved in Tumor suppression and its Dysregulation in Oral Cancer
-
批准号:16209054
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$29.37万
-
财政年份:2004
-
负责人:IKEDA Masa-aki
-
依托单位:
Alternations of the Transcriptional Co-activator p300 in Oral Cancers and Its Novel Role in Tumor Suppression
-
批准号:10470400
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.7万
-
财政年份:1998
-
负责人:IKEDA Masa-aki
-
依托单位:
海外基金